Please login to the form below

Not currently logged in
Email:
Password:

Zavicefta

This page shows the latest Zavicefta news and features for those working in and with pharma, biotech and healthcare.

Merck preps regulatory filings for much-needed antibiotic combo

Merck preps regulatory filings for much-needed antibiotic combo

It’s been sold in Europe by Pfizer as Zavicefta since 2016.

Latest news

  • Allergan’s Avycaz breaks Gram-negative pneumonia antibiotic drought Allergan’s Avycaz breaks Gram-negative pneumonia antibiotic drought

    The antibiotic is sold in Europe by Pfizer under the Zavicefta brand name and got a green light from the EMA in 2016. ... Zavicefta is already approved in Europe for HABP/VABP. One of the key roles for the new product is in the treatment of infections

  • Pfizer launches antibiotic resistance surveillance website Pfizer launches antibiotic resistance surveillance website

    Meanwhile, Pfizer’s new antibiotic for multidrug resistant (MDR) infections, Zavicefta, was launched in its first European markets earlier this year after the pharma firm paid its developer AstraZeneca $1.58bn

  • Pfizer launches new antibiotic Zavicefta in UK and Germany Pfizer launches new antibiotic Zavicefta in UK and Germany

    Pfizer launches new antibiotic Zavicefta in UK and Germany. Biopharmaceutical company Pfizer releases MDR antibiotic. ... Pfizer's new antibiotic for multidrug resistant (MDR) infections - Zavicefta - has been launched in the UK and Germany, its first EU

  • AZ slims down again with sale of antibiotics to Pfizer AZ slims down again with sale of antibiotics to Pfizer

    The deal includes the approved antibiotics Merrem (meropenem), Zinforo (ceftaroline fosamil) and just-licensed Zavicefta (ceftazidime/avibactam), as well as two injectable antibiotic candidates - Allergan-partnered ATM-AVI (aztreonam/avibactam) and

  • AZ gets EU green light for new antibiotic Zavicefta AZ gets EU green light for new antibiotic Zavicefta

    AZ gets EU green light for new antibiotic Zavicefta. EMA approves combination drug for treatment of multidrug resistant infections. ... AstraZeneca's new antibiotic for multidrug resistant (MDR) infections - Zavicefta - has been approved for marketing in

More from news
Approximately 4 fully matching, plus 4 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
bmore group

OUR PROMISE: BETTER HEALTH FROM TRIAL TO TREATMENT.We are a full service, independent network of specialist agencies under one roof....

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics